Global Infertility Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 262115
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Infertility Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Infertility Drugs market size is estimated to be worth US$ 5313.5 million in 2021 and is forecast to a readjusted size of USD 7560.7 million by 2028 with a CAGR of 5.2% during review period. Male accounting for % of the Infertility Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gonadotropins segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Infertility Drugs include Merck, Ferring, MSD, LIVZON, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Infertility Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Gonadotropins

Anti-Estrogens

Other

Market segment by Application, can be divided into

Male

Female

Market segment by players, this report covers

Merck

Ferring

MSD

LIVZON

Abbott

Bayer Zydus Pharma

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Infertility Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Infertility Drugs, with revenue, gross margin and global market share of Infertility Drugs from 2019 to 2022.

Chapter 3, the Infertility Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Infertility Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Infertility Drugs research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Infertility Drugs

1.2 Classification of Infertility Drugs by Type

1.2.1 Overview: Global Infertility Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Infertility Drugs Revenue Market Share by Type in 2021

1.2.3 Gonadotropins

1.2.4 Anti-Estrogens

1.2.5 Other

1.3 Global Infertility Drugs Market by Application

1.3.1 Overview: Global Infertility Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Male

1.3.3 Female

1.4 Global Infertility Drugs Market Size & Forecast

1.5 Global Infertility Drugs Market Size and Forecast by Region

1.5.1 Global Infertility Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Infertility Drugs Market Size by Region, (2017-2022)

1.5.3 North America Infertility Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Infertility Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Infertility Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Infertility Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Infertility Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Infertility Drugs Market Drivers

1.6.2 Infertility Drugs Market Restraints

1.6.3 Infertility Drugs Trends Analysis

2 Company Profiles

2.1 Merck

2.1.1 Merck Details

2.1.2 Merck Major Business

2.1.3 Merck Infertility Drugs Product and Solutions

2.1.4 Merck Infertility Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Merck Recent Developments and Future Plans

2.2 Ferring

2.2.1 Ferring Details

2.2.2 Ferring Major Business

2.2.3 Ferring Infertility Drugs Product and Solutions

2.2.4 Ferring Infertility Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Ferring Recent Developments and Future Plans

2.3 MSD

2.3.1 MSD Details

2.3.2 MSD Major Business

2.3.3 MSD Infertility Drugs Product and Solutions

2.3.4 MSD Infertility Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 MSD Recent Developments and Future Plans

2.4 LIVZON

2.4.1 LIVZON Details

2.4.2 LIVZON Major Business

2.4.3 LIVZON Infertility Drugs Product and Solutions

2.4.4 LIVZON Infertility Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 LIVZON Recent Developments and Future Plans

2.5 Abbott

2.5.1 Abbott Details

2.5.2 Abbott Major Business

2.5.3 Abbott Infertility Drugs Product and Solutions

2.5.4 Abbott Infertility Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Abbott Recent Developments and Future Plans

2.6 Bayer Zydus Pharma

2.6.1 Bayer Zydus Pharma Details

2.6.2 Bayer Zydus Pharma Major Business

2.6.3 Bayer Zydus Pharma Infertility Drugs Product and Solutions

2.6.4 Bayer Zydus Pharma Infertility Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bayer Zydus Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Infertility Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Infertility Drugs Players Market Share in 2021

3.2.2 Top 10 Infertility Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Infertility Drugs Players Head Office, Products and Services Provided

3.4 Infertility Drugs Mergers & Acquisitions

3.5 Infertility Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Infertility Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Infertility Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Infertility Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Infertility Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Infertility Drugs Revenue by Type (2017-2028)

6.2 North America Infertility Drugs Revenue by Application (2017-2028)

6.3 North America Infertility Drugs Market Size by Country

6.3.1 North America Infertility Drugs Revenue by Country (2017-2028)

6.3.2 United States Infertility Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Infertility Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Infertility Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Infertility Drugs Revenue by Type (2017-2028)

7.2 Europe Infertility Drugs Revenue by Application (2017-2028)

7.3 Europe Infertility Drugs Market Size by Country

7.3.1 Europe Infertility Drugs Revenue by Country (2017-2028)

7.3.2 Germany Infertility Drugs Market Size and Forecast (2017-2028)

7.3.3 France Infertility Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Infertility Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Infertility Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Infertility Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Infertility Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Infertility Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Infertility Drugs Market Size by Region

8.3.1 Asia-Pacific Infertility Drugs Revenue by Region (2017-2028)

8.3.2 China Infertility Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Infertility Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Infertility Drugs Market Size and Forecast (2017-2028)

8.3.5 India Infertility Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Infertility Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Infertility Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Infertility Drugs Revenue by Type (2017-2028)

9.2 South America Infertility Drugs Revenue by Application (2017-2028)

9.3 South America Infertility Drugs Market Size by Country

9.3.1 South America Infertility Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Infertility Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Infertility Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Infertility Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Infertility Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Infertility Drugs Market Size by Country

10.3.1 Middle East & Africa Infertility Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Infertility Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Infertility Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Infertility Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Infertility Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Infertility Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Infertility Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Infertility Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Infertility Drugs Revenue Market Share by Region (2023-2028)

Table 6. Merck Corporate Information, Head Office, and Major Competitors

Table 7. Merck Major Business

Table 8. Merck Infertility Drugs Product and Solutions

Table 9. Merck Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Ferring Corporate Information, Head Office, and Major Competitors

Table 11. Ferring Major Business

Table 12. Ferring Infertility Drugs Product and Solutions

Table 13. Ferring Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. MSD Corporate Information, Head Office, and Major Competitors

Table 15. MSD Major Business

Table 16. MSD Infertility Drugs Product and Solutions

Table 17. MSD Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. LIVZON Corporate Information, Head Office, and Major Competitors

Table 19. LIVZON Major Business

Table 20. LIVZON Infertility Drugs Product and Solutions

Table 21. LIVZON Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Abbott Corporate Information, Head Office, and Major Competitors

Table 23. Abbott Major Business

Table 24. Abbott Infertility Drugs Product and Solutions

Table 25. Abbott Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bayer Zydus Pharma Corporate Information, Head Office, and Major Competitors

Table 27. Bayer Zydus Pharma Major Business

Table 28. Bayer Zydus Pharma Infertility Drugs Product and Solutions

Table 29. Bayer Zydus Pharma Infertility Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Global Infertility Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 31. Global Infertility Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 32. Breakdown of Infertility Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. Infertility Drugs Players Head Office, Products and Services Provided

Table 34. Infertility Drugs Mergers & Acquisitions in the Past Five Years

Table 35. Infertility Drugs New Entrants and Expansion Plans

Table 36. Global Infertility Drugs Revenue (USD Million) by Type (2017-2022)

Table 37. Global Infertility Drugs Revenue Share by Type (2017-2022)

Table 38. Global Infertility Drugs Revenue Forecast by Type (2023-2028)

Table 39. Global Infertility Drugs Revenue by Application (2017-2022)

Table 40. Global Infertility Drugs Revenue Forecast by Application (2023-2028)

Table 41. North America Infertility Drugs Revenue by Type (2017-2022) & (USD Million)

Table 42. North America Infertility Drugs Revenue by Type (2023-2028) & (USD Million)

Table 43. North America Infertility Drugs Revenue by Application (2017-2022) & (USD Million)

Table 44. North America Infertility Drugs Revenue by Application (2023-2028) & (USD Million)

Table 45. North America Infertility Drugs Revenue by Country (2017-2022) & (USD Million)

Table 46. North America Infertility Drugs Revenue by Country (2023-2028) & (USD Million)

Table 47. Europe Infertility Drugs Revenue by Type (2017-2022) & (USD Million)

Table 48. Europe Infertility Drugs Revenue by Type (2023-2028) & (USD Million)

Table 49. Europe Infertility Drugs Revenue by Application (2017-2022) & (USD Million)

Table 50. Europe Infertility Drugs Revenue by Application (2023-2028) & (USD Million)

Table 51. Europe Infertility Drugs Revenue by Country (2017-2022) & (USD Million)

Table 52. Europe Infertility Drugs Revenue by Country (2023-2028) & (USD Million)

Table 53. Asia-Pacific Infertility Drugs Revenue by Type (2017-2022) & (USD Million)

Table 54. Asia-Pacific Infertility Drugs Revenue by Type (2023-2028) & (USD Million)

Table 55. Asia-Pacific Infertility Drugs Revenue by Application (2017-2022) & (USD Million)

Table 56. Asia-Pacific Infertility Drugs Revenue by Application (2023-2028) & (USD Million)

Table 57. Asia-Pacific Infertility Drugs Revenue by Region (2017-2022) & (USD Million)

Table 58. Asia-Pacific Infertility Drugs Revenue by Region (2023-2028) & (USD Million)

Table 59. South America Infertility Drugs Revenue by Type (2017-2022) & (USD Million)

Table 60. South America Infertility Drugs Revenue by Type (2023-2028) & (USD Million)

Table 61. South America Infertility Drugs Revenue by Application (2017-2022) & (USD Million)

Table 62. South America Infertility Drugs Revenue by Application (2023-2028) & (USD Million)

Table 63. South America Infertility Drugs Revenue by Country (2017-2022) & (USD Million)

Table 64. South America Infertility Drugs Revenue by Country (2023-2028) & (USD Million)

Table 65. Middle East & Africa Infertility Drugs Revenue by Type (2017-2022) & (USD Million)

Table 66. Middle East & Africa Infertility Drugs Revenue by Type (2023-2028) & (USD Million)

Table 67. Middle East & Africa Infertility Drugs Revenue by Application (2017-2022) & (USD Million)

Table 68. Middle East & Africa Infertility Drugs Revenue by Application (2023-2028) & (USD Million)

Table 69. Middle East & Africa Infertility Drugs Revenue by Country (2017-2022) & (USD Million)

Table 70. Middle East & Africa Infertility Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Infertility Drugs Picture

Figure 2. Global Infertility Drugs Revenue Market Share by Type in 2021

Figure 3. Gonadotropins

Figure 4. Anti-Estrogens

Figure 5. Other

Figure 6. Infertility Drugs Revenue Market Share by Application in 2021

Figure 7. Male Picture

Figure 8. Female Picture

Figure 9. Global Infertility Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Infertility Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Infertility Drugs Revenue Market Share by Region (2017-2028)

Figure 12. Global Infertility Drugs Revenue Market Share by Region in 2021

Figure 13. North America Infertility Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Infertility Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Infertility Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Infertility Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Infertility Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Infertility Drugs Market Drivers

Figure 19. Infertility Drugs Market Restraints

Figure 20. Infertility Drugs Market Trends

Figure 21. Merck Recent Developments and Future Plans

Figure 22. Ferring Recent Developments and Future Plans

Figure 23. MSD Recent Developments and Future Plans

Figure 24. LIVZON Recent Developments and Future Plans

Figure 25. Abbott Recent Developments and Future Plans

Figure 26. Bayer Zydus Pharma Recent Developments and Future Plans

Figure 27. Global Infertility Drugs Revenue Share by Players in 2021

Figure 28. Infertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 29. Global Top 3 Players Infertility Drugs Revenue Market Share in 2021

Figure 30. Global Top 10 Players Infertility Drugs Revenue Market Share in 2021

Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 32. Global Infertility Drugs Revenue Share by Type in 2021

Figure 33. Global Infertility Drugs Market Share Forecast by Type (2023-2028)

Figure 34. Global Infertility Drugs Revenue Share by Application in 2021

Figure 35. Global Infertility Drugs Market Share Forecast by Application (2023-2028)

Figure 36. North America Infertility Drugs Sales Market Share by Type (2017-2028)

Figure 37. North America Infertility Drugs Sales Market Share by Application (2017-2028)

Figure 38. North America Infertility Drugs Revenue Market Share by Country (2017-2028)

Figure 39. United States Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Canada Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Mexico Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Europe Infertility Drugs Sales Market Share by Type (2017-2028)

Figure 43. Europe Infertility Drugs Sales Market Share by Application (2017-2028)

Figure 44. Europe Infertility Drugs Revenue Market Share by Country (2017-2028)

Figure 45. Germany Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. France Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. United Kingdom Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Russia Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Italy Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Asia-Pacific Infertility Drugs Sales Market Share by Type (2017-2028)

Figure 51. Asia-Pacific Infertility Drugs Sales Market Share by Application (2017-2028)

Figure 52. Asia-Pacific Infertility Drugs Revenue Market Share by Region (2017-2028)

Figure 53. China Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Japan Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. South Korea Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. India Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Southeast Asia Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Australia Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South America Infertility Drugs Sales Market Share by Type (2017-2028)

Figure 60. South America Infertility Drugs Sales Market Share by Application (2017-2028)

Figure 61. South America Infertility Drugs Revenue Market Share by Country (2017-2028)

Figure 62. Brazil Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Argentina Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Middle East and Africa Infertility Drugs Sales Market Share by Type (2017-2028)

Figure 65. Middle East and Africa Infertility Drugs Sales Market Share by Application (2017-2028)

Figure 66. Middle East and Africa Infertility Drugs Revenue Market Share by Country (2017-2028)

Figure 67. Turkey Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Saudi Arabia Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. UAE Infertility Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Methodology

Figure 71. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz